ProQR Therapeutics N.V. buy Cantor Fitzgerald
Start price
29.04.25
/
50%
€1.38
Target price
29.04.26
€7.02
Performance (%)
23.66%
Price
17.04.26
€1.62
Summary
This prediction is currently active. The prediction currently has a performance of 23.66%. This prediction currently runs until 29.04.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| ProQR Therapeutics N.V. | 3.918% | 3.918% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $8.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.84
27.06.25
27.06.25
€6.84
27.06.26
27.06.26
-7.34%
17.04.26
17.04.26
